Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine

Pediatrics

Volumn 119, Issue 1, 2007, Pages 171-181

  Bocchini Jr , Joseph A ^h   Baltimore, Robert S ^h   Bernstein, Henry H ^h   Bradley, John S ^h   Brady, Michael T ^h   Dennehy, Penelope H ^h   Fisher, Margaret C ^h   Frenck Jr , Robert W ^h   Kimberlin, David W ^h   Long, Sarah S ^h   McMillan, Julia A ^h   Rubin, Lorry G ^h   Clover, Richard D ^h   Fischer, Marc A ^a   Gorman, Richard L ^b   Pratt, Douglas R ^c   Schuchat, Anne ^d   Schwartz, Benjamin ^b   Starke, Jeffrey R ^e   Swanson, Jack ^f,g   Pickering, Larry K ^h   Ledbetter, Edgar O ^h   Siwek, Alison ^h   more..

^a AMERICAN ACADEMY OF FAMILY PHYSICIANS   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e National Vaccine Program Office   (United States)

^f American Thoracic Society   (United States)

^g Practice Action Group

^h NONE

Author keywords

Rotavirus gastroenteritis; Rotavirus vaccine

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE; LIVE VACCINE;

ANTIGEN DETECTION; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEVER; GASTROENTERITIS; HEMATOCHEZIA; HUMAN; IMMUNOCOMPETENCE; IMMUNOGENICITY; INTUSSUSCEPTION; OTITIS MEDIA; PRIORITY JOURNAL; REVIEW; RHINOPHARYNGITIS; ROTAVIRUS; VIRUS INFECTION; VOMITING; ARTICLE; FECES; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; NEWBORN; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRACTICE GUIDELINE; PREMATURITY; RISK FACTOR; UNITED STATES; VIROLOGY;

ADMINISTRATION, ORAL; FECES; GASTROENTERITIS; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; RISK FACTORS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES; VACCINES, ATTENUATED;

EID: 33846938614     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3134     Document Type: Review

References (58)

1. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335:1022-1028
2. Zaki AM, DuPont HL, El Alamy MA, et al. The detection of enteropathogens in acute diarrhea in a family cohort population in rural Egypt. Am J Trop Med Hyg. 1986;35:1013-1022
3. Simhon A, Mata L, Vives M, et al. Low endemicity and low pathogenicity of rotaviruses among rural children in Costa Rica. J Infect Dis. 1985;152:1134-1142
4. Rodriguez WJ, Kim HW, Brandt CD, et al. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr Infect Dis J. 1987;6:170-176
5. Black RE, Lopez de Romana G, Brown KH, Bravo N, Bazalar OG, Kanashiro HC. Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru. Am J Epidemiol. 1989;129:785-799
6. Jin S, Kilgore PE, Holman RC, Clarke MJ, Gangarosa EJ, Glass RI. Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J. 1996;15:397-404
7. Parashar UD, Holman RC, Clarke MJ, Bresee JS, Glass RI. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis. 1998;177:13-17
8. Avery ME, Snyder JD. Oral therapy for acute diarrhea: the underused simple solution. N Engl J Med. 1990;323:891-894
9. King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16
10. Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis. 1993;168:282-287
11. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med. 1983;309:72-76
12. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33
13. Gurwith M, Wenman W, Gurwith D, Brunton J, Feltham S, Greenberg H. Diarrhea among infants and young children in Canada: a longitudinal study in three northern communities. J Infect Dis. 1983;147:685-692
14. Glass RI, Kilgore PE, Holman RC, et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis. 1996;174(suppl 1):S5-S11
15. Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279:1371-1376
16. Wilhelmi I, Roman E, Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect. 2003;9:247-262
17. Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis. 2004;17:461-469
18. Brandt CD, Kim HW, Rodriguez WJ, et al. Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol. 1983;18:71-78
19. Koopman JS, Turkish VJ, Monto AS, Gouvea V, Srivastava S, Isaacson RE. Patterns and etiology of diarrhea in three clinical settings. Am J Epidemiol. 1984;119:114-123
20. Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis. 1990;162:598-604
21. Rodriguez WJ, Kim HW, Brandt CD, et al. Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital. Am J Dis Child. 1980;134:777-779
22. Fruhwirth M, Heininger U, Ehlken B, et al. International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection. Pediatr Infect Dis J. 2001;20:784-791
23. Fischer TK, Bresee JS, Glass RI. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine. 2004;22(suppl 1):S49-S54
24. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med. 2000;154:586-593
25. Reves RR, Morrow AL, Bartlett AV III, et al. Child day care increases the risk of clinic visits for acute diarrhea and diarrhea due to rotavirus. Am J Epidemiol. 1993;137:97-107
26. Bartlett AV, Moore M, Gary GW, Starko KM, Erben JJ, Meredith BA. Diarrheal illness among infants and toddlers in day care centers. I. Epidemiology and pathogens. J Pediatr. 1985;107:495-502
27. LeBaron CW, Lew J, Glass RI, Weber JM, Ruiz-Palacios GM. Annual rotavirus epidemic patterns in North America: results of a 5-year retrospective survey of 88 centers in Canada, Mexico, and the United States. Rotavirus Study Group. JAMA. 1990;264:983-988
28. Torok TJ, Kilgore PE, Clarke MJ, Holman RC, Bresee JS, Glass RI. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996. National Respiratory and Enteric Virus Surveillance System Collaborating Laboratories. Pediatr Infect Dis J. 1997;16:941-946
29. Fischer TK, Gentsch JR. Rotavirus typing methods and algorithms. Rev Med Virol. 2004;14:71-82
30. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29-56
31. Flewett TH. Rotavirus in the home and hospital nursery. Br Med J (Clin Res Ed). 1983;287:568-569
32. Bishop RF. Natural history of human rotavirus infection. Arch Virol Suppl. 1996;12:119-128
33. Pickering LK, Bartlett AV III, Reves RR, Morrow A. Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J Pediatr. 1988;112:361-365
34. Galil A, Antverg R, Katzir G, et al. Involvement of infants, children, and adults in a rotavirus gastroenteritis outbreak in a kibbutz in southern Israel. J Med Virol. 1986;18:317-326
35. Hrdy DB. Epidemiology of rotaviral infection in adults. Rev Infect Dis. 1987;9:461-469
36. Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002;21:221-227
37. Carlson JA, Middleton PJ, Szymanski MT, Huber J, Petric M. Fatal rotavirus gastroenteritis: an analysis of 21 cases. Am J Dis Child. 1978;132:477-479
38. Gurwith M, Wenman W, Hinde D, Feltham S, Greenberg H. A prospective study of rotavirus infection in infants and young children. J Infect Dis. 1981;144:218-224
39. Widdowson MA, Bresee JS, Gentsch JR, Glass RI. Rotavirus disease and its prevention. Curr Opin Gastroenterol. 2005;21:26-31
40. Iturriza-Gomara M, Auchterlonie IA, Zaw W, Molyneaux P, Desselberger U, Gray J. Rotavirus gastroenteritis and central nervous system (CNS) infection: characterization of the VP7 and VP4 genes of rotavirus strains isolated from paired fecal and cerebrospinal fluid samples from a child with CNS disease. J Clin Microbiol. 2002;40:4797-4979
41. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol. 2004;78:10213-10220
42. Chiappini E, Azzari C, Moriondo M, Galli L, de Martino M. Viraemia is a common finding in immunocompetent children with rotavirus infection. J Med Virol. 2005;76:265-267
43. Saulsbury FT, Winkelstein JA, Yolken RH. Chronic rotavirus infection in immunodeficiency. J Pediatr. 1980;97:61-65
44. Yolken RH, Bishop CA, Townsend TR. Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med. 1982;306:1010-1012
45. Troussard X, Bauduer F, Gallet E, et al. Virus recovery from stools of patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1993;12:573-576
46. Liakopoulou E, Mutton K, Carrington D, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2005;36:691-694
47. Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics. 1999;103(1). Available at: www.pediatrics.org/cgi/content/full/103/1/e3
48. RotaTeq [package insert]. Whitehouse Station, NJ: Merck & Co Inc; 2006. Available at: www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi. pdf. Accessed August 25, 2006
49. Block S, Vesikari T, Goveia M, et al. Efficacy, immunogenicity, and safety of a polyvalent rotavirus vaccine (RotaTeq) at expiry potency in healthy infants. Paper presented at: the 39th National Immunization Conference; Washington, DC; March 21-25, 2005
50. Vesikari T, Matson D, Dennehy P, et al. Efficacy of the pentavalent rotavirus vaccine in subjects after 1 or 2 doses in the Rotavirus Efficacy & Safety Trial (REST). Paper presented at: the 44th annual meeting of the Infectious Disease Society of America; October 12-15, 2006; Toronto, Ontario, Canada
51. Joensuu J, Koskenniemi E, Vesikari T. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. Pediatr Infect Dis J. 1998;17:334-340
52. Vesikari T, Varis T, Green K, Flores J, Kapikian AZ. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity. Vaccine. 1991;9:334-339
53. Vesikari T, Kapikian AZ, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis. 1986;153:832-839
54. Atkinson WL, Pickering LK, Schwartz B, et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep. 2002;51(RR-2):1-35
55. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22
56. Iwamoto M, Saari TN, McMahon SR, et al. A survey of pediatricians on the reintroduction of a rotavirus vaccine. Pediatrics. 2003;112(1). Available at: www.pediatrics.org/cgi/content/full/112/1/e6
57. Parashar UD, Alexander JP, Glass RI; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2006;55(RR-12):1-13
58. Clark HF, Bernstein DI, Dennehy PH, et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants [published correction appears in J Pediatr. 2004;144:558]. J Pediatr. 2004;144:184-190